| Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte. | |
| | |
MedLine Citation:
|
PMID: 12939210 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Percutaneous transluminal coronary angioplasty of the infarct-related artery in stable survivors of acute myocardial infarction is often performed, even in patients without any symptoms or residual ischemia. Despite the lack of randomized studies, it is widely believed that this intervention will improve the clinical outcome of these patients. METHODS AND RESULTS: Three hundred patients with single vessel disease of the infarct vessel and no or minor angina pectoris in the subacute phase (1 to 6 weeks) after an acute myocardial infarction were randomized to angioplasty (n=149) or medical therapy (n=151). Primary end point was the survival free of reinfarction, (re)intervention, coronary artery bypass surgery, or readmission for severe angina pectoris at 1 year. The event-free survival at 1 year was 82% in the medical group and 90% in the angioplasty group (P=0.06). This difference was mainly driven by the difference in the need for (re)interventions (20 versus 8, P=0.03). At long-term follow-up (mean, 56 months), survival was 89% and 96% (P=0.02). Survival free of reinfarction, (re)intervention, or coronary artery bypass surgery was 66% and 80% in the medically and interventionally treated patients, respectively (P=0.05). The use of nitrates was significantly lower in the angioplasty group, both at 1 year (38% versus 67%, P=0.001) and at long-term follow-up (36% versus 55%, P=0.006). CONCLUSIONS: Percutaneous revascularization of the infarct-related coronary artery in stable patients with single vessel disease improves clinical outcome at long-term follow-up and reduces the use of nitrates. The results of our study should be reproduced in a confirmatory study with a larger sample size before percutaneous coronary intervention in this low-risk patient subgroup, after myocardial infarction can be recommended as routine treatment in clinical practice. |
| | |
Authors:
|
Uwe Zeymer; Rainer Uebis; Albrecht Vogt; Hans-Georg Glunz; Hans-Friedrich Vöhringer; Dietrich Harmjanz; Karl-Ludwig Neuhaus; |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't Date: 2003-08-25 |
Journal Detail:
|
Title: Circulation Volume: 108 ISSN: 1524-4539 ISO Abbreviation: Circulation Publication Date: 2003 Sep |
Date Detail:
|
Created Date: 2003-09-16 Completed Date: 2003-09-30 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0147763 Medline TA: Circulation Country: United States |
Other Details:
|
Languages: eng Pagination: 1324-8 Citation Subset: AIM; IM |
Affiliation:
|
Medizinische Klinik II, Klinikum Kassel, Berlin, Germany. Uwe.Zeymer@t-online.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary* Coronary Angiography Coronary Artery Disease / diagnosis, drug therapy, therapy Disease-Free Survival Female Follow-Up Studies Humans Male Middle Aged Myocardial Infarction / diagnosis, drug therapy, therapy* Survivors Thrombolytic Therapy Treatment Outcome |
| Comments/Corrections | |
Comment In:
|
Circulation. 2003 Sep 16;108(11):1292-4
[PMID:
12975243
]
Circulation. 2003 Sep 16;108(11):e9027-33 [PMID: 12975248 ] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Risk stratification after acute myocardial infarction by heart rate turbulence.
Next Document: Rapid left-to-right shunt quantification in children by phase-contrast magnetic resonance imaging co...